These drugs mimic the production of a hormone called glucagon-like peptide-1, which boosts insulin production, slows digestion and regulates appetite, thus lowering blood sugar and supporting weight management
Your healthcare team can provide you with more information if you are interested, or you may contact Novo Nordisk at 1-800-727-6500
As the results shown, patients with different CVDs imply various responses in terms of gut microbial diversity, abundance, and homogeneity
But Medicare, the government-backed insurance that covers most adults 65 years or age and older, wont pay for weight loss medications
In India alone, the GLP-1 therapy market is expected to grow to reach about USD 180 million in 2024 and is estimated to increase by 15-18% every year to 2035 due to awareness, development of healthcare infrastructure, and availability of pricing